CBT
WST icon

Central Bank & Trust’s West Pharmaceutical WST Stock Holding History

Central Bank & Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3
Closed -$1.06K – 364
2023
Q4 		$1.06K Hold
3
– – ﹤0.01% 345
2023
Q3 		$1.13K Hold
3
– – ﹤0.01% 325
2023
Q2 		$1.15K Sell
3
-9
-75% -$3.21K ﹤0.01% 314
2023
Q1 		$4.16K Buy
+12
New +$3.51K ﹤0.01% 317

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Central Bank & Trust's WST Position: Q1 2024 in Review

Central Bank & Trust sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 3 shares — an estimated $1.06K sold.

Central Bank & Trust first reported a position in WST in Q1 2023 and held it in 4 quarters. The position peaked at $4.16K in Q1 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Central Bank & Trust reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Central Bank & Trust sold 3 West Pharmaceutical shares in Q1 2024, an estimated $1.06K.
  • Central Bank & Trust first reported a position in West Pharmaceutical in Q1 2023 and held it in 4 quarters.
  • Central Bank & Trust's West Pharmaceutical position peaked at $4.16K in Q1 2023.
  • 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Central Bank & Trust's 13F filing for Q1 2024, filed 11 Apr 2024.